Epidemiology of visceral leishmaniasis, Clin Epidemiol. 3 mai, vol.6, pp.147-54, 2014. ,
, Visceral Leishmaniasis: Recent Advances in Diagnostics and 267
, Treatment Regimens. Infect Dis Clin North Am, vol.33, issue.1, pp.79-99, 2019.
, Références bibliographiques
La leishmaniose viscérale infantile ,
Leishmaniasis worldwide and global estimates of its incidence, den Boer, M., and WHO Leishmaniasis Control Team, vol.7, p.35671, 2012. ,
The relationship between leishmaniasis and AIDS: the second 10 years, Clin. Microbiol. Rev, vol.21, pp.334-359, 2008. ,
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a singlecenter, 8-year experience in Italy and review of the literature, Clin. Infect. Dis, vol.44, pp.1602-1610, 2007. ,
Actualités épidémiologiques de la leishmaniose viscérale en Tunisie, 2009. ,
New perspectives on a subclinical form of visceral leishmaniasis, J. Infect. Dis, vol.154, pp.1003-1011, 1986. ,
, , 2010.
, Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic, J. Clin. Microbiol, vol.48, pp.131-136
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease, Cochrane Database Syst Rev CD009135, 2014. ,
Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example, Cell. Microbiol, vol.10, pp.1221-1234, 2008. ,
Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs, Vet. Immunol. Immunopathol, vol.128, pp.71-78, 2009. ,
, , 2008.
, Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis, J. Acquir. Immune Defic. Syndr, vol.48, pp.13-19
Active chronic visceral leishmaniasis" in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients, HIV Med, vol.11, pp.670-673, 2010. ,
Traitement des leishmanioses en France : proposition d'un référentiel consensuel, La Presse Médicale, vol.40, pp.173-184, 2011. ,
, Rapport annuel d'activité, CNRL, 2019.
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis, J. Clin. Microbiol, vol.44, pp.2343-2347, 2006. ,
On the presence of peculiar parasitic organisms in the tissue of a specimen of Delhi boil (Calcutta: Printed by the Superintendent of government printing, 1885. ,
The biological diagnosis of leishmaniasis in HIV-infected patients, Ann Trop Med Parasitol, vol.97, issue.1, pp.115-133, 2003. ,
Leishmania/HIV co-infections: epidemiology in Europe, Ann Trop Med Parasitol, vol.97, pp.3-15, 2003. ,
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis, Rev. Soc. Bras. Med. Trop, vol.49, pp.398-407, 2016. ,
85 années de leishmaniose au Maroc ,
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis, PLoS Negl Trop Dis, vol.13, p.7484, 2019. ,
, , 1999.
, Presse Med, vol.28, pp.2057-2066
Canine Leishmania vaccines: still a long way to go, Vet. Parasitol, vol.208, pp.94-100, 2015. ,
Haute Autorité de santé, vol.54, 2017. ,
Leishmaniasis in AIDS patients: results of leukocytoconcentration, a fast biological method of diagnosis, Bull. World Health Organ, vol.74, pp.91-93, 1996. ,
Optimized PCR using patient blood samples for diagnosis and followup of visceral Leishmaniasis, with special reference to AIDS patients, J. Clin. Microbiol, vol.38, pp.236-240, 2000. ,
Evolution, classification and geographical distribution, 1987. ,
ON THE POSSIBILITY OF THE OCCURRENCE OF TRYPANOSOMIASIS IN INDIA, British Medical Journal, vol.1, p.1252, 1903. ,
A Newly Revised Classification of the Protozoa*, The Journal of Protozoology, vol.27, pp.37-58, 1980. ,
Epidemiology of the leishmaniases, 1995. ,
Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up, Am. J. Trop. Med. Hyg, vol.75, pp.858-863, 2006. ,
Evaluation of PCR for Diagnosis of Indian Kala-Azar and Assessment of Cure, J Clin Microbiol, vol.43, pp.3038-3041, 2005. ,
Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients, Parasite Immunol, vol.13, pp.531-536, 1991. ,
Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Trop, vol.119, pp.69-75, 2011. ,
Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs, PLoS Negl Trop Dis, vol.6, 1683. ,
, Principaux repères sur la leishmaniose, OMS, 2019.
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar, Trans. R. Soc. Trop. Med. Hyg, vol.69, pp.60-68, 1975. ,
Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece, J. Infect, vol.50, pp.53-60, 2005. ,
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis, Clin. Diagn. Lab. Immunol, vol.12, pp.1164-1167, 2005. ,
Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up, Eur. J. Clin. Microbiol. Infect. Dis, vol.23, pp.899-904, 2004. ,
Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil, Parasitol. Res, vol.106, pp.377-386, 2010. ,
Leishmaniasis: current status of available drugs and new potential drug targets, Asian Pac J Trop Med, vol.5, pp.485-497, 2012. ,
Trial of oral miltefosine for visceral leishmaniasis, Lancet, vol.352, pp.1821-1823, 1998. ,
Leishmaniasis worldwide and global estimates of its incidence, den Boer, M., and WHO Leishmaniasis Control Team, vol.7, p.35671, 2012. ,
, , 1986.
, J. Infect. Dis, vol.154, pp.1003-1011
Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example, Cell. Microbiol, vol.10, pp.1221-1234, 2008. ,
Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs, Vet. Immunol. Immunopathol, vol.128, pp.71-78, 2009. ,
,
Traitement des leishmanioses en France : proposition d'un référentiel consensuel, La Presse Médicale, vol.40, pp.173-184, 2011. ,
On the presence of peculiar parasitic organisms in the tissue of a specimen of Delhi boil (Calcutta: Printed by the Superintendent of government printing, 1885. ,
Leishmania/HIV co-infections: epidemiology in Europe, 2003. ,
, Ann Trop Med Parasitol 97 Suppl, vol.1, pp.3-15
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis, Rev. Soc. Bras. Med. Trop, vol.49, pp.398-407, 2016. ,
, , 1999.
, Presse Med, vol.28, pp.2057-2066
Canine Leishmania vaccines: still a long way to go, Vet. Parasitol, vol.208, pp.94-100, 2015. ,
Haute Autorité de santé, vol.54, 2017. ,
Evolution, classification and geographical distribution, 1987. ,
ON THE POSSIBILITY OF THE OCCURRENCE OF TRYPANOSOMIASIS IN INDIA, British Medical Journal, vol.1, p.1252, 1903. ,
A Newly Revised Classification of the Protozoa*, The Journal of Protozoology, vol.27, pp.37-58, 1980. ,
Epidemiology of the leishmaniases, 1995. ,
Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up, Am. J. Trop. Med. Hyg, vol.75, pp.858-863, 2006. ,
Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients, Parasite Immunol, vol.13, pp.531-536, 1991. ,
Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Trop, vol.119, pp.69-75, 2011. ,
Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs, PLoS Negl Trop Dis, vol.6, 1683. ,
, Principaux repères sur la leishmaniose, OMS, 2019.
One Health: The global challenge of epidemic and endemic leishmaniasis | Parasites & Vectors | Full Text, 2011. ,
, , 1975.
, Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar, Trans. R. Soc. Trop. Med. Hyg, vol.69, pp.60-68
Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece, J. Infect, vol.50, pp.53-60, 2005. ,
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis, Clin. Diagn. Lab. Immunol, vol.12, pp.1164-1167, 2005. ,
Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil, Parasitol. Res, vol.106, pp.377-386, 2010. ,
Leishmaniasis: vaccine candidates and perspectives, Vaccine, vol.30, pp.3834-3842, 2012. ,
Leishmaniasis: current status of available drugs and new potential drug targets, Asian Pac J Trop Med, vol.5, pp.485-497, 2012. ,
Trial of oral miltefosine for visceral leishmaniasis, Lancet, vol.352, pp.1821-1823, 1998. ,